Ambrobene 60 mg 20 effervescent tablets
Ambrobene 60 mg effervescent tablets are used to treat wet (productive) cough in acute and chronic respiratory diseases in adults and adolescents from 12 years of age. Examples of these respiratory diseases are acute inflammations of the larynx, trachea or bronchi and chronic diseases such as chronic bronchitis (inflammation of the bronchi) and chronic obstructive pulmonary disease. For chronic diseases of the respiratory tract, this medicinal product can only be used after consulting a doctor .
A wet (productive) cough is associated with disorders of the lungs and bronchi during the production of excess mucus . Ambrobene works by making the mucus thinner and loosening it so that it can be coughed up more easily.
The package contains 20 effervescent tablets.
Dosage and method of use
Adults and adolescents from 12 years of age
Half an effervescent tablet of Ambrobene 60 mg three times a day (equivalent to 90 mg of ambroxol hydrochloride per day) during the first 2-3 days. Then half an effervescent tablet of Ambrobene 60 mg twice a day (equivalent to 60 mg ambroxol hydrochloride daily).
In adults and adolescents from 12 years of age, the dose can be increased, if necessary, up to 60 mg of ambroxol hydrochloride twice a day (equivalent to 120 mg of ambroxol hydrochloride per day).
The active substance is ambroxol hydrochloride. One effervescent tablet contains 60 mg of ambroxol hydrochloride.
Excipients are: citric acid (E 330), sodium bicarbonate (E 500 (ii)), sodium carbonate (E 500 (i)), sodium saccharin (E 954), sodium cyclamate (E 952), sodium chloride, sodium citrate (E 331) ), lactose, mannitol (E 421), sorbitol (E 420), simethicone, cherry aroma (natural/naturally identical aromatic substances (containing benzyl alcohol (E 1519), propylene glycol (E 1520)), maltodextrin, mannitol (E 421) ), gluconolactone (E 575), sorbitol (E 420), gum arabic (E 414), colloidal anhydrous silica (E 551)).
Read the package leaflet carefully. Ambrobene should not be used during pregnancy, especially during the first three months. Ambrobene is not recommended for women who are breastfeeding.